CTMX Chart
- 52-Week Range: $1.53 - $8.22
- Market Capitalization: $110.85M
- Short Percentage: 0%
- Target Price: $12.00
- Shares Outstanding: 65.40M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
CTMX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- CytomX Therapeutics to Report First Quarter 2022 Financial Results on May 5, 2022GlobeNewsWire | April 28th
- CytomX Therapeutics Announces Retirement of Frederick W. Gluck from Board of DirectorsGlobeNewsWire | March 23rd
- CytomX Therapeutics, Inc. (CTMX) CEO Sean McCarthy on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha | March 1st
- CytomX Therapeutics to Present at Cowen 42nd Annual Healthcare ConferenceGlobeNewsWire | February 28th
- CytomX Therapeutics to Report Fourth Quarter and Full Year 2021 Financial Results on March 1, 2022GlobeNewsWire | February 22nd
- CytomX Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire | January 5th
Company Info
Website: https://www.cytomx.com
Address: 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 174
Address: 151 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Sector: Healthcare
Industry: Biotechnology
Full time employees: 174
$CTMX who else finds themselves here after liquidating their positions for a loss only to bash on how seriously fcked up the stock market is
$CTMX what a horse shit show!
$CTMX starting to gap up a little
$CTMX what happens?
$CTMX pump up the volume
$CTMX power hour will be fucking crazy
$CTMX let’s go baby!
$CTMX rip and dip today bulls
$CTMX breaking out